Skip to main content

Table 3 Subgroup analysis

From: Effects of pseudoephedrine on parameters affecting exercise performance: a meta-analysis

  

HR

TT

RPE

GLU

LAC

Subgroup

Median split

Effect size

Groups

N

Effect size

Groups

N

Effect size

Groups

N

Effect size

Groups

N

Effect size

Groups

N

PSE dose

> 170 mg

0.85

6

49

− 0.24

6

54

0.00

2

16

− 0.08

3

24

− 0.09

5

56

≤ 170 mg

0.11

5

48

− 0.06

4

37

− 0.11

3

37

− 0.41

2

13

− 0.51

1

7

Exercise duration

≥ 25 mins

0.38

6

49

− 0.08

7

61

0.02

3

23

− 0.08

3

24

− 0.10

4

34

< 25 mins

0.55

5

48

− 0.34

3

30

− 0.16

2

30

− 0.41

2

13

− 0.18

2

29

Age

> 28 years

0.32

7

60

− 0.12

6

51

0.02

3

23

− 0.08

3

24

− 0.10

4

34

< 28 years

0.77

4

37

− 0.22

4

40

− 0.16

2

30

− 0.41

2

13

− 0.18

2

29

VO2 max

≥ 65 ml/kg/min

0.69

4

33

− 0.40

4

35

− 0.31

1

10

− 0.18

3

25

− 0.52

2

15

< 65 ml/kg/min

0.07

4

37

− 0.10

3

26

− 0.06

3

36

− 0.27

1

6

0.05

3

26

Washout period (days)

≥ 7 days

0.65

5

45

− 0.19

5

50

− 0.16

2

30

− 0.07

3

21

0.00

4

47

< 7 days

0.31

6

52

− 0.14

5

41

0.02

3

23

− 0.36

2

16

− 0.51

2

16

Pre-exercise ingestion time

≥ 90 min

0.41

6

57

− 0.10

6

58

− 0.31

1

10

− 0.18

3

25

0.03

3

25

< 90 min

0.54

5

40

− 0.34

3

26

− 0.06

3

36

− 0.21

2

12

− 0.30

3

38

Mode of exercise

Cycling

0.77

6

52

− 0.09

6

54

− 0.04

3

36

− 0.36

2

16

0.00

4

48

Running

0.18

5

45

− 0.16

2

20

− 0.36

1

10

− 0.07

3

21

− 0.52

2

15

  1. PSE, pseudoephedrine; HR, heart rate; RPE, rate of perceived exertion; TT, time trial; GLU, blood glucose; LAC, blood lactate; min, minute(s); VO2max, maximum oxygen uptake